Tevogen Inc. Shareholders' Equity
Tevogen Inc. (TVGN) had Shareholders' Equity of -$8.89 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$8.89M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$9.84M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$8.23M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$7.82M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$8.89M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$9.84M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | -$8.23M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$7.82M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$9.48M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | -$7.72M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | -$6.67M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | -$6.19M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$7.66M 10-Q · filed 2025-11-14 | -$7.63M 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$5.80M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | -$94.43M 10-K · filed 2026-03-31 | -$17.38M 10-K · filed 2024-04-29 |
| 2023-09-30 | -$90.80M 10-Q · filed 2024-11-19 | -$16.16M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$86.89M 10-Q · filed 2024-11-19 | -$15.55M 10-Q · filed 2023-08-21 |
| 2023-03-31 | -$64.71M 10-Q · filed 2024-11-19 | -$15.33M 10-Q · filed 2023-05-22 |
| 2022-12-31 | -$33.95M 10-K · filed 2025-04-02 | -$14.78M 10-K · filed 2023-04-17 |
| 2022-09-30 | -$14.66M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$14.05M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | -$14.25M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | -$14.23M 10-K · filed 2024-04-29 | |
| 2021-09-30 | $13.59K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $13.70K 10-Q · filed 2022-11-14 | |
| 2021-04-30 | $18.02K 10-Q · filed 2021-12-17 | |
| 2021-04-21 | $0.00 10-K · filed 2023-04-17 | |
| 2021-04-20 | $0.00 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B |